Research Progress on Postoperative Adjuvant Therapy for Completely Resected Stage ⅠB Non-small Cell Lung Cancer

Research Progress on Postoperative Adjuvant Therapy for Completely Resected Stage ⅠB Non-small Cell Lung Cancer

Lung cancer is considered as the leading cause of cancer-related mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for about 85% of primary lung cancer. Owing to the improved utilization of medical technological level and the popularization of health examinations, the detection rate o...

Full description

Bibliographic Details
Main Authors: MA Shishi, DAI Yuran, CHEN Xiaopin
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-03-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
non-small cell lung cancer
adjuvant chemotherapy
targeted therapy
immunotherapy
prognostic factors
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.0933

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.0933

Similar Items